| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/13/2011 | CN102120764A Angiogenesis of triple mutant low-oxygen inducible factor 1 alpha induced by auxiliary activating factors and application thereof |
| 07/13/2011 | CN102120038A Gene treatment medicament capable of inhabiting immunoreaction caused by transgenosis products and preparation method thereof |
| 07/13/2011 | CN102120037A Human epididymis secretion sperm bonding protein HEL-S-64C as well as coding gene and application thereof |
| 07/13/2011 | CN102119925A Protein nano particle with tissue factor targeting property and preparation method and application thereof |
| 07/13/2011 | CN101518644B Application of Ang-2 and genes thereof in pharmacy |
| 07/13/2011 | CN101376893B Herpes simplex virus vector, recombinant virus, host cell and pharmaceutical composition thereof |
| 07/13/2011 | CN101376892B Herpes simplex virus vector, recombinant virus, host cell and pharmaceutical composition thereof |
| 07/13/2011 | CN101065482B Novel shuttle vector |
| 07/12/2011 | US7977468 Chromosome 3p21.3 genes are tumor suppressors |
| 07/12/2011 | US7977316 Prevention and treatment of amyloidogenic diseases |
| 07/12/2011 | US7977312 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
| 07/12/2011 | US7977091 Eukaryotic layered vector initiation systems |
| 07/12/2011 | US7977049 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 07/12/2011 | US7976864 Film preparation and process for preparing the same |
| 07/12/2011 | US7976848 Optimized expression of HPV 58 L1 in yeast |
| 07/12/2011 | US7976846 Stress protein complex; a grp170 polypeptide and an immunogenic polypeptide; antitumor |
| 07/12/2011 | US7976836 Treatment of stroke using placental stem cells |
| 07/12/2011 | US7976826 Compositions and methods relating to prevention of chemotherapy-induced alopecia |
| 07/12/2011 | CA2461443C Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 07/12/2011 | CA2457528C Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina) |
| 07/12/2011 | CA2448947C Pseudotyping vih-1 vectors with the aid of rhabdovirus envelopes |
| 07/12/2011 | CA2446776C Self-containing lactococcus strain |
| 07/12/2011 | CA2405438C Hepatitis b core antigen fusion proteins |
| 07/12/2011 | CA2364095C Production of radial glial cells |
| 07/12/2011 | CA2352286C Intracellular targeted delivery of compounds by 70 kd heat shock protein |
| 07/12/2011 | CA2302874C Jnk3 modulators and methods of use |
| 07/12/2011 | CA2277850C Genetic alterations associated with cancer |
| 07/12/2011 | CA2220442C Chromatin regulator genes |
| 07/07/2011 | WO2011082409A2 Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8 |
| 07/07/2011 | WO2011082388A2 Infectious dna vaccines against chikungunya virus |
| 07/07/2011 | WO2011081939A1 Direct sensing of molecular species by polyfluors on a dna backbone |
| 07/07/2011 | WO2011079520A1 Polyethylene glycol-poly(lactic-co-glycolic acid)-poly(l-lysine), preparation method and use as drug/gene carrier thereof |
| 07/07/2011 | WO2011066511A8 Synthetic apoa-1 mimetic amphipathic peptides and methods of use thereof |
| 07/07/2011 | WO2011054976A3 Novel viral vector construct for neuron specific continuous dopa synthesis in vivo |
| 07/07/2011 | WO2011053790A3 Assay of closely linked genetic targets in fetal diagnosis |
| 07/07/2011 | WO2011021916A3 Use of egf-like domain of heregulin beta 1 peptide |
| 07/07/2011 | WO2011018636A3 Photochemical internalization method |
| 07/07/2011 | WO2011018635A3 Photosensitizing compositions |
| 07/07/2011 | WO2011010098A3 Methods |
| 07/07/2011 | WO2010109176A3 Parenteral pharmaceutical composition for use in gene therapy |
| 07/07/2011 | US20110166212 Gene expression and pain |
| 07/07/2011 | US20110166208 Nucleotide and Amino Acid Sequences for Calmodulin Protein Methyltransferase |
| 07/07/2011 | US20110166207 Use of aav integration efficiency element for mediating site-specific integration of a transcription unit |
| 07/07/2011 | US20110166065 Modulation of glucose-6-phosphatase translocase expression |
| 07/07/2011 | US20110165653 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 07/07/2011 | US20110165197 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 07/07/2011 | US20110165180 Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses |
| 07/07/2011 | US20110165166 Lsr receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 07/07/2011 | US20110165148 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/07/2011 | CA2785832A1 Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8 |
| 07/07/2011 | CA2785727A1 Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3) |
| 07/06/2011 | EP2341346A2 Methods of high-throughput screening for internalizing antibodies and metal-chelating liposomes |
| 07/06/2011 | EP2341148A2 Diagnosis and treatment of cancer |
| 07/06/2011 | EP2341143A1 OX2 receptor homolog |
| 07/06/2011 | EP2341142A2 HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising same |
| 07/06/2011 | EP2341073A2 RAB9A, RAB11A, and modulators thereof related to infectious disease |
| 07/06/2011 | EP2341071A1 Compostion and methods for increasing bone mineralization |
| 07/06/2011 | EP2341068A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 07/06/2011 | EP2341060A1 Molecules with extended half-lives, compositions and uses thereof |
| 07/06/2011 | EP2341058A2 Oligonucleotide Analogues |
| 07/06/2011 | EP2341057A2 Oligonucleotide Analogues |
| 07/06/2011 | EP2340845A2 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |
| 07/06/2011 | EP2340831A1 HT0712 for the treatment of a cognitive deficit |
| 07/06/2011 | EP2340040A2 Modulation of axon degeneration |
| 07/06/2011 | EP1587834B1 Uses of il-23 mammalian cytokine; related reagents |
| 07/06/2011 | EP1450611B1 Method for the generation of antigen-specific lymphocytes |
| 07/06/2011 | CN1871034B Methods and compositions for cancer therapy using a novel adenovirus |
| 07/06/2011 | CN102119217A Novel lipid formulations for nucleic acid delivery |
| 07/06/2011 | CN102115787A MicroRNA (Ribose Nucleic Acid) and application of antisensenucleic acid of microRNA to diagnosis, prevention, treatment and/or prognostic evaluation of heart disease |
| 07/06/2011 | CN102115748A Danio rerio B-lymphocyte activating factor (zBAFF) cDNA (complementary deoxyribonucleic acid), and cloning method and application thereof in recombination |
| 07/06/2011 | CN102115747A cDNA (complementary deoxyribonucleic acid) of horse tumor necrosis factor superfamily member 13B (horse TNFSF 13B), and cloning method, recombination and application thereof |
| 07/06/2011 | CN102115733A Construction method and application of hepatic tumor gene treatment system capable of administrating intravenously |
| 07/06/2011 | CN102115494A Tick antibacterial peptide, gene thereof and application of same |
| 07/06/2011 | CN102114000A Co-feeding lipid nano-delivery system for medicine carrying |
| 07/06/2011 | CN101759170B Magnetic nano sheet-shaped hydroxyapatite and preparation method and application thereof |
| 07/06/2011 | CN101538569B RNA and recombinant for inhibiting human DMT1 protein and application thereof |
| 07/06/2011 | CN101199862B B7-1, CD40L mass particle mixture |
| 07/06/2011 | CN101014608B Methods and compositions for the inhibition of gene expression |
| 07/05/2011 | US7973156 Hypoxia-regulated genes |
| 07/05/2011 | US7973148 Crustacean expression vector |
| 07/05/2011 | US7973143 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 07/05/2011 | US7973019 Transferrin/transferrin receptor-mediated siRNA delivery |
| 07/05/2011 | US7973018 Cell cycle arrest and apoptosis |
| 07/05/2011 | US7973017 For treatment of endocrine-regulated tumors, for example, breast, prostate, ovarian and colon cancers |
| 07/05/2011 | US7973015 Induction of exon skipping in eukaryotic cells |
| 07/05/2011 | US7972856 Targeted gene modification by parvoviral vectors |
| 07/05/2011 | US7972844 Nuclear factor κB inducing factor |
| 07/05/2011 | US7972777 Nucleic acid probe-based diagnostic assays targeting ssrA genes of prokaryotic and eukaryotic organisms |
| 07/05/2011 | US7972772 KIF11 and method for diagnosing non-small cell lung cancer |
| 07/05/2011 | US7972661 Electrospraying method with conductivity control |
| 07/05/2011 | US7972607 Attenuated francisella and methods of use |
| 07/05/2011 | US7972601 Method of promoting delivery of an antioxidant agent to a cell expression neuroligin |
| 07/05/2011 | US7972593 Delivery of therapeutic agents to the bone |
| 07/05/2011 | US7972592 Prevention of type 1 diabetes and other non-polio enterovirus diseases |
| 07/05/2011 | CA2390081C Modified viral surface proteins which bind to cells of tumor vasculature |
| 07/05/2011 | CA2190290C A method of inducing an immune response using vaccinia virus recombinants |
| 06/30/2011 | WO2011079263A2 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2 |
| 06/30/2011 | WO2011079261A2 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf |
| 06/30/2011 | WO2011079070A1 Furin-knockdown bi-functional rna |
| 06/30/2011 | WO2011078037A1 Aging marker, method for evaluating aging inhibitor, and cancer inhibitor |